1. Chernoff AI, Minnich V, Nanakorn S, Tuchinda S, Kashemsant C, Bangkok, et al. Studies on hemoglobin E. I. The clinical, hematologic, and genetic characteristics of the hemoglobin E syndromes. J Lab Clin Med. 1956;47:455–89.
2. Bain BJ. Other significant haemoglobinopathies. In: Haemoglobinopathy diagnosis. 2nd ed. Oxford: Blackwell Publishing Ltd; 2006. p. 190–233.
3. Balgir RS. Aberrant heterosis in hemoglobinopathies with special reference to Beta-Thalassemia and structurally abnormal hemoglobins E and S in Orissa, India. JCDR (serial online) 2007 June (cited: 2014 Jul 22); (1): 122–130. Available from http://www.jcdr.net/back_issues.asp?issn=0973-709x&year=2007&month=June&volume=1&issue=3&page=122-130&id=68 .
4. Mandal AK, Bhat V, Mathew B. Analysis of hemoglobin variants using nondenaturing gel electrophoresis and matrix-assisted laser desorption ionization mass. Anal Biochem. 2011;416(1):135–7.
5. Najmabadi H, Teimourian S, Khatibi T, Neishabury M, Oberkanins C, Krugluger W, et al. Amplification refractory mutation system (ARMS) and reverse hybridization in the detection of Beta-thalassemia mutations. Arch Irn Med. 2001;4(4):165–70.